These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 17507542)
21. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Isacson J; Trollfors B; Taranger J; Lagergård T Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057 [TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Wang CQ; Zhu QR Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963 [TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Gonik B; Puder KS; Gonik N; Kruger M Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994 [TBL] [Abstract][Full Text] [Related]
25. Serological responses to infection with B. pertussis. Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353 [TBL] [Abstract][Full Text] [Related]
26. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085 [TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. Zhang Q; Han F; Nie Q; Ren H; Zhang B; Liu Q; He Q; Shao Z J Infect; 2011 Dec; 63(6):441-6. PubMed ID: 21864569 [TBL] [Abstract][Full Text] [Related]
28. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. Thomas MG; Ashworth LA; Miller E; Lambert HP J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651 [TBL] [Abstract][Full Text] [Related]
29. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis. Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677 [TBL] [Abstract][Full Text] [Related]
30. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. Hallander HO; Ljungman M; Storsaeter J; Gustafsson L APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530 [TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey. Ozkal A; Sensoy G; Acuner C; Belet N; Güney AK Turk J Pediatr; 2012; 54(1):15-9. PubMed ID: 22397036 [TBL] [Abstract][Full Text] [Related]
32. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey]. Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881 [TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children. Syed MA; Ahmed W; Naeem A; Bokhari H J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160 [TBL] [Abstract][Full Text] [Related]
34. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects. Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470 [TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia. Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of serologic assays for diagnosis of whooping cough. Granström G; Wretlind B; Salenstedt CR; Granström M J Clin Microbiol; 1988 Sep; 26(9):1818-23. PubMed ID: 2903178 [TBL] [Abstract][Full Text] [Related]
38. Characterization of serological responses to pertussis. Watanabe M; Connelly B; Weiss AA Clin Vaccine Immunol; 2006 Mar; 13(3):341-8. PubMed ID: 16522775 [TBL] [Abstract][Full Text] [Related]
39. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection. Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250 [TBL] [Abstract][Full Text] [Related]
40. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Baughman AL; Bisgard KM; Edwards KM; Guris D; Decker MD; Holland K; Meade BD; Lynn F Clin Diagn Lab Immunol; 2004 Nov; 11(6):1045-53. PubMed ID: 15539504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]